Abstract
In 227 of 495 (45.9%) Japanese adult patients with acute myelocytic leukemia (AML), leukemic cells expressed CD4. Incidence of CD4 expression in each FAB subtype was as follows: M1 37.4%, M2 33.7%, M3 35.4%, M4 65.0%, and M5 78.3%. The typical expression pattern of myelomonocytic differentiation antigens and cytokine receptors in CD4+ AML was CD34lowCD33high CD11bhighGM-CSFRhigh. AML cases with 11q23 abnormalities and with inv(16) were frequently CD4-positive. These data collectively indicate that CD4 expression in AML cells is associated with monocytic characteristics. However, CD4+CD34high AML cases appear to have unique immature characteristics including low expression of myelomonocytic differentiation antigens (ie CD33 and CD11b), and accumulation of chromosome abnormalities (ie t(8;21) in CD4lowCD34high AML and chromosome 7 abnormalities in CD4highCD34high AML). We speculate that these leukemia subsets originate from CD4+ hematopoietic precursor cells, therefore then should be considered separately from most of the CD4+ AML as represented by CD34lowCD33high CD11bhighGM-CSFRhigh. Overall survival of patients with CD4+ AML in our series was worse than that of those with CD4 AML (P = 0.0202).
Citations
Aug 8, 2002·Cancer Genetics and Cytogenetics·M Tarek ElghetanyGopalrao V N Velagaleti
Jun 7, 2006·Hematology·Lotfy A MahmoudEnas F A Goda
Dec 21, 2006·Hematology·Guillermo J Ruiz-ArgüellesVirginia Reyes-Núñez
Dec 22, 2009·American Journal of Clinical Pathology·Jennifer LuoHong Chang
Dec 15, 2004·Clinical and Laboratory Haematology·M SłomkowskiE Mendek-Czajkowska
Mar 3, 2004·Cytometry. Part B, Clinical Cytometry·Jolanta Woźniak, Joanna Kopeć-Szlezak
Jun 30, 2007·European Journal of Haematology·Yasuo MoriMine Harada
Sep 17, 2015·PloS One·Kazunori NakaseNaoyuki Katayama
Sep 28, 2005·Blood Reviews·Kylie D MasonJeff Szer
May 25, 2004·Oncogene·Yoshiaki Ito
Feb 21, 2018·Bone Marrow Transplantation·Kiyosumi OchiTakahiro Fukuda
Sep 13, 2005·Oncogene·Michael D LairmoreLee Ratner
Jan 31, 2008·Leukemia & Lymphoma·Maria KrajTomasz Szpila
Jan 20, 2018·Oncotarget·Kevin G PinzYupo Ma
Jun 2, 2020·Leukemia & Lymphoma·Lu NieZunmin Zhu
Mar 21, 2019·Frontiers in Oncology·Lauren D SchererMaksim Mamonkin
Dec 2, 2020·Molecular & Cellular Proteomics : MCP·Ka-Won KangYong Park
Feb 17, 2021·Molecular & Cellular Proteomics : MCP·Ka-Won KangYong Park